Find trials
Consejos para buscar

Home Telemonitoring In Patients After Myocardial Infarction

Overview

Información sobre este estudio

The purpose of this study is to evaluate patients undergoing cardiac catheterization. The hypothesis is that patients who go home with 12 lead ECG home telemonitoring will have decreased general and cardiac ED presentation and hospital readmission rates without an increase in major adverse cardiac events and at a lower health care utilization cost compared to patients with standard therapy alone.

Elegibilidad para la participación

Los requisitos de elegibilidad de los participantes incluyen la edad, el sexo, el tipo y el estadio de la enfermedad, y los problemas de salud o tratamientos previos. Las pautas difieren de un estudio a otro e identifican quiénes pueden o no pueden participar. No hay garantía de que cada persona elegible que desee participar en un ensayo se inscribirá. Comunícate con el equipo del estudio para analizar la elegibilidad del estudio y la posible participación.

Inclusion Criteria:

  • ≥ 18 years of age.
  • Acute myocardial infarction, STEMI and NSTEMI.
  • Ability to use the device at home.
  • Must have smartphone device with home wi-fi/internet available which allow 24-7 ability to transmit ECG.
  • Caring family member who will be able to perform the ECG in case the patient himself/herself won't be able to do it.

Exclusion Criteria:

  • No ability to use the device at home.
  • No smartphone device or home wi-fi/mobile internet which prevent 24/7 ability to transmit ECG.
  • Cannot download the smartheart app.
  • No support in home environment.
  • Out of hospital cardiac arrest: secondary to a non-shockable rhythm, unrelated to an acute coronary syndrome, or with any level of neurologic damage.
  • Resident of nursing home or acute care facility
  • Uninterpretable ECG at discharge – left bundle branch block (LBBB), pacemaker or implantable cardioverter defibrillator (ICD) with pacing dependence.
  • Patients who are planned for staged PCI after the index hospitalization.

Eligibility last updated 1/13/22. Questions regarding updates should be directed to the study team contact.

Sedes participantes de Mayo Clinic

Los estatus de los estudios cambian con frecuencia. Comunícate con el equipo del estudio para obtener la información más actualizada acerca de la posibilidad de participar.

Sede de Mayo Clinic Estatus Contacto

Rochester, Minn.

Investigador principal de Mayo Clinic

Joerg Herrmann, M.D.

Cerrado para la inscripción

Contact information:

Sarah Devamani M.S.

(507) 255-0876

Devamani.Sarah@mayo.edu

More information

Publicaciones

Publications are currently not available

Otros temas en investigación

.
CLS-20502819

Mayo Clinic Footer